ANCN—>CMMB following 1:4 reverse split, pursuant to previously announced reverse-merger: https://www.prnewswire.com/news-releases/chemomab-completes-merger-with-anchiano-therapeutics-301248816.html The company also raised $45.5M in a private placement.